Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD)
12:00am, Saturday, 01'st Aug 2020
San Diego, California--(Newsfile Corp. - July 31, 2020) - If you would like to discuss your legal rights email [email protected] or call (619) 780-3993. ACADIA Pharmaceuticals (ACAD) Accused of Misleadi
SHAREHOLDER ALERT: Stephens & Stephens LLP Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD)
07:37pm, Thursday, 30'th Jul 2020
Stephens & Stephens LLP is investigating the officers and directors of ACADIA Pharmaceuticals Inc. (NasdaqGS: ACAD) for breach of fiduciary duties on the part of its directors and management.
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:33pm, Wednesday, 29'th Jul 2020
Acadia (ACAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
People with Dementia and Caregivers Share the Significant Burden of Visual Hallucinations and Paranoid Delusions, New Survey Highlights
01:00pm, Wednesday, 29'th Jul 2020
UsAgainstAlzheimer’s, the Lewy Body Dementia Association and ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the results of a qualitative and quantitative survey that explored the impact
ACADIA Pharmaceuticals (ACAD) Investor Presentation - Slideshow
07:27am, Wednesday, 29'th Jul 2020
The following slide deck was published by ACADIA Pharmaceuticals Inc. in conjunction with this event..
ACADIA (ACAD) to Report Q2 Earnings: What's in the Cards?
03:33pm, Tuesday, 28'th Jul 2020
ACADIA's (ACAD) second-quarter 2020 results are likely to reflect lower revenues from Nuplazid due to the adverse impacts of COVID-19.
Analysts' Top Healthcare Picks: Protalix Biotherapeutics (PLX), ACADIA Pharmaceuticals (ACAD) - Markets
10:25am, Monday, 27'th Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Protalix Biotherapeutics
Brokerages Expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Will Announce Earnings of -$0.45 Per Share
06:32am, Monday, 27'th Jul 2020
Brokerages expect that ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) will post earnings per share (EPS) of ($0.45) for the current quarter, according to Zacks Investment Research. Six analysts have made e
ACADIA Pharmaceuticals to Announce Second Quarter 2020 Financial Results on August 5, 2020
08:05pm, Wednesday, 22'nd Jul 2020
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter financial results on Wednesday, August 5, 2020, after the close of the U.S. financial markets. ACADIA’s
Stocks Little Changed As Risk-On Trade Comes Into Focus
12:00am, Wednesday, 22'nd Jul 2020
Stocks Analysis by Michael Kramer covering: SPDR S&P 500, Amazon.com Inc, Freeport-McMoran Copper & Gold Inc, US Dollar Index Futures. Read Michael Kramer's latest article on Investing.com
Acadia Pharma Dives On Unexpected Flop In Depression Treatment
08:24pm, Tuesday, 21'st Jul 2020
Acadia Pharmaceuticals said Tuesday its experimental depression treatment failed in a Phase 3 study — prompting ACAD stock to plunge. That put shares near their lowest point this month.
Charting a bull-flag breakout, S&P 500 extends rally as volatility recedes
04:24pm, Tuesday, 21'st Jul 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish, and continues to strengthen, amid recently receding volatility, writes...
Acadia Plunges 12% As Depressive Study Misses Goals; Analyst Says Buy
07:46am, Tuesday, 21'st Jul 2020
Shares in Acadia Pharmaceuticals (ACAD) plunged 12% in Monday’s extended trading, after the company announced disappointing top-line results from its 298 patient Phase 3 CLARITY study evaluating pim
Mid-Afternoon Market Update: Silver Jumps Over 7%; Immuron Shares Spike Higher
12:00am, Tuesday, 21'st Jul 2020
Toward the end of trading Tuesday, the Dow traded up 1.01% to 26949.66 while the NASDAQ fell 0.04% to 10,770.41. The S&P also rose, gaining 0.66% to 3,273.14.
The U.S. has the...
U.S. FDA accepts Acadia's application for dementia drug
09:30pm, Monday, 20'th Jul 2020
The U.S. Food and Drug Administration on Monday accepted Acadia Pharmaceuticals Inc's application for an antipsychotic drug to treat dementia patients with hallucinations and delusions. The drug, Nup
